Laird Norton Wetherby Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$15.7M Sell
84,722
-1,422
-2% -$244K 0.64% 21
2025
Q2
$13.2M Buy
+86,144
New +$13.2M 0.59% 21
2024
Q4
$11.2M Sell
77,245
-5,989
-7% -$928K 0.54% 26
2024
Q3
$13.5M Buy
83,234
+5,094
+7% +$812K 0.62% 23
2024
Q2
$11.4M Sell
78,140
-6,862
-8% -$1.02M 0.54% 27
2024
Q1
$13.4M Buy
85,002
+1,751
+2% +$279K 0.64% 21
2023
Q4
$13M Sell
83,251
-13,701
-14% -$2.1M 0.68% 19
2023
Q3
$15.1M Sell
96,952
-3,381
-3% -$558K 0.86% 12
2023
Q2
$16.6M Buy
100,333
+13,759
+16% +$2.22M 0.89% 11
2023
Q1
$13.4M Sell
86,574
-13,366
-13% -$2.16M 0.79% 14
2022
Q4
$17.7M Buy
99,940
+3,012
+3% +$520K 1.13% 9
2022
Q3
$15.8M Buy
96,928
+880
+0.9% +$149K 1.12% 10
2022
Q2
$17.1M Buy
96,048
+13,706
+17% +$2.44M 1.16% 9
2022
Q1
$14.6M Buy
82,342
+4,178
+5% +$711K 0.84% 15
2021
Q4
$13.4M Buy
78,164
+888
+1% +$145K 0.75% 17
2021
Q3
$12.5M Buy
77,276
+918
+1% +$157K 0.77% 15
2021
Q2
$12.6M Buy
76,358
+10,406
+16% +$1.72M 0.77% 16
2021
Q1
$10.8M Sell
65,952
-8,868
-12% -$1.43M 0.83% 18
2020
Q4
$11.8M Buy
74,820
+8,136
+12% +$1.2M 0.8% 16
2020
Q3
$9.93M Sell
66,684
-3,058
-4% -$452K 0.88% 15
2020
Q2
$9.81M Buy
69,742
+4,174
+6% +$608K 0.93% 14
2020
Q1
$8.6M Buy
65,568
+3,690
+6% +$524K 0.97% 14
2019
Q4
$9.03M Sell
61,878
-1,887
-3% -$256K 0.89% 18
2019
Q3
$8.25M Sell
63,765
-702
-1% -$92.5K 0.86% 19
2019
Q2
$8.98M Buy
64,467
+2,701
+4% +$374K 0.98% 14
2019
Q1
$8.63M Buy
61,766
+637
+1% +$85.3K 1.08% 11
2018
Q4
$7.89M Buy
61,129
+1,225
+2% +$171K 1.12% 10
2018
Q3
$8.28M Buy
59,904
+492
+0.8% +$65.4K 1.02% 12
2018
Q2
$7.21M Sell
59,412
-2,459
-4% -$307K 0.98% 13
2018
Q1
$7.93M Sell
61,871
-1,432
-2% -$194K 1.09% 11
2017
Q4
$8.85M Buy
63,303
+1,552
+3% +$216K 1.23% 9
2017
Q3
$8.03M Buy
61,751
+446
+0.7% +$59.1K 1.19% 10
2017
Q2
$8.11M Buy
61,305
+2,500
+4% +$319K 1.38% 6
2017
Q1
$7.32M Buy
58,805
+3,203
+6% +$383K 1.32% 7
2016
Q4
$6.41M Sell
55,602
-914
-2% -$106K 1.25% 8
2016
Q3
$6.68M Buy
56,516
+2,762
+5% +$335K 1.35% 8
2016
Q2
$6.52M Buy
53,754
+1,359
+3% +$154K 1.45% 7
2016
Q1
$5.67M Buy
52,395
+3,180
+6% +$329K 1.34% 12
2015
Q4
$5.05M Buy
49,215
+1,269
+3% +$128K 1.21% 11
2015
Q3
$4.48M Buy
47,946
+1,255
+3% +$121K 1.15% 14
2015
Q2
$4.55M Buy
46,691
+2,220
+5% +$222K 1.09% 15
2015
Q1
$4.47M Buy
44,471
+1,041
+2% +$106K 1.09% 13
2014
Q4
$4.54M Buy
43,430
+686
+2% +$72.3K 1.14% 13
2014
Q3
$4.56M Sell
42,744
-123
-0.3% -$12.8K 1.27% 12
2014
Q2
$4.49M Buy
42,867
+604
+1% +$61K 1.27% 11
2014
Q1
$4.15M Sell
42,263
-926
-2% -$85.8K 1.19% 11
2013
Q4
$3.96M Buy
43,189
+958
+2% +$88.3K 1.13% 12
2013
Q3
$3.66M Buy
42,231
+1,104
+3% +$99K 1.14% 14
2013
Q2
$3.53M Buy
+41,127
New +$3.49M 1.23% 15

Other funds holding JNJ

Laird Norton Wetherby Wealth Management's JNJ Position: Q3 2025 in Review

Laird Norton Wetherby Wealth Management reduced its Johnson & Johnson (JNJ) stake by 1.7% in Q3 2025, selling an estimated $244K and leaving 84,722 shares worth $15.7M. The position accounts for 0.64% of the portfolio, ranked #21.

Laird Norton Wetherby Wealth Management first reported a position in JNJ in Q2 2013 and has held it in 49 quarters since. The position peaked at $17.7M in Q4 2022. 4,187 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.

  • Laird Norton Wetherby Wealth Management held 84,722 shares of Johnson & Johnson worth $15.7M as of Q3 2025.
  • Laird Norton Wetherby Wealth Management sold 1,422 Johnson & Johnson shares in Q3 2025, an estimated $244K.
  • Johnson & Johnson made up 0.64% of Laird Norton Wetherby Wealth Management's portfolio in Q3 2025, its #21 holding.
  • Laird Norton Wetherby Wealth Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 49 quarters since.
  • Laird Norton Wetherby Wealth Management's Johnson & Johnson position peaked at $17.7M in Q4 2022.
  • 4,187 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.

Based on Laird Norton Wetherby Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.